{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:05:41Z","timestamp":1772820341665,"version":"3.50.1"},"reference-count":68,"publisher":"Pan American Health Organization","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,6]]},"abstract":"<title>ABSTRACT<\/title>\n                  <p>The growing burden of noncommunicable diseases (NCDs) cannot be addressed through clinical interventions alone. Population-level regulatory interventions\u2014such as fiscal measures, marketing restrictions, and labeling regulations\u2014are central to effective NCD prevention and control. This article addresses the role of regulatory policies in preventing NCDs, with a focus on progress and implementation gaps in the Americas. In the context of NCDs, unhealthy commodity industries, including companies that produce and promote tobacco, alcohol, and ultra-processed food products, play a significant role in shaping patterns of NCD risk. Their activities influence not only the availability, access, and affordability of unhealthy commodities but also misinform the public\u2019s perception about what is healthy. These industries shape trends in consumption and harm while actively working to expand markets and influence regulatory environments in ways that may delay or dilute effective public health measures. Although considerable progress has been made in recent years, most Member States have not fully met their international commitments to regulate unhealthy commodities industries, products, practices, and policies. The fabrication of NCD epidemics due to the unhealthy commodities industries moves faster and stronger than the capacity to improve care for NCDs in the absence of effective policies to regulate these corporations\u2019 products, practices, and policies. Therefore, an essential component of the improvement of care for NCDs in the Americas is the strengthening of the regulatory capacities of Member States to regulate tobacco, alcohol, and ultra-processed products industries and to safeguard policies from their interference.<\/p>","DOI":"10.26633\/rpsp.2026.11","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:58:43Z","timestamp":1772798323000},"page":"1","source":"Crossref","is-referenced-by-count":0,"title":["The role of regulatory policies on unhealthy commodities to prevent and control noncommunicable diseases in the Americas"],"prefix":"10.26633","volume":"50","author":[{"given":"Fabio S.","family":"Gomes","sequence":"first","affiliation":[{"name":"Risk Factors and Nutrition Unit, Department of Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, United States of America."},{"name":"gomesfabio@paho.org"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Carolina","family":"Sandoval","sequence":"additional","affiliation":[{"name":"Risk Factors and Nutrition Unit, Department of Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itziar","family":"Belausteguigoitia","sequence":"additional","affiliation":[{"name":"Risk Factors and Nutrition Unit, Department of Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Cristina","family":"Mena","sequence":"additional","affiliation":[{"name":"Risk Factors and Nutrition Unit, Department of Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Ceron Diaz","sequence":"additional","affiliation":[{"name":"Risk Factors and Nutrition Unit, Department of Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul Martin","family":"del Campo","sequence":"additional","affiliation":[{"name":"Mental Health and Substance Use Unit, Department of Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Garcia-Larsen","sequence":"additional","affiliation":[{"name":"Risk Factors and Nutrition Unit, Department of Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11167","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Murphy A, Palafox B, Walli-Attaei M, Powell-Jackson T, Rangarajan S, Alhabib KF, et al. The household economic burden of non-communicable diseases in 18 countries. BMJ Glob Health. 2020;5(2):e002040. https:\/\/doi.org\/10.1136\/bmjgh-2019-002040","DOI":"10.1136\/bmjgh-2019-002040"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Muka T, Imo D, Jaspers L, Colpani V, Chaker L, van der Lee SJ, et al. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review. Eur J Epidemiol. 2015;30(4):251\u201377. https:\/\/doi.org\/10.1007\/s10654-014-9984-2","DOI":"10.1007\/s10654-014-9984-2"},{"key":"ref3","unstructured":"Commission on Social Determinants of Health. Closing the gap in a generation: health equity through action on the social determinants of health. Final Report of the Commission on Social Determinants of Health. Geneva: World Health Organization; 2008."},{"key":"ref4","unstructured":"World Health Organization (WHO). Tackling NCDs: best buys and other recommended interventions for the prevention and control of noncommunicable diseases, 2nd edition. Geneva: WHO; 2024."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Mialon M, Gomes FDS. Public health and the ultra-processed food and drink products industry: corporate political activity of major transnationals in Latin America and the Caribbean. Public Health Nutr. 2019;22(10):1898\u2013908. https:\/\/doi.org\/10.1017\/S1368980019000417","DOI":"10.1017\/S1368980019000417"},{"key":"ref6","unstructured":"Pan American Health Organization (PAHO). Report on tobacco control for the Region of the Americas 2022. Washington, DC: PAHO; 2022."},{"key":"ref7","unstructured":"Pan American Health Organization (PAHO). Regional status report on alcohol and health 2020. Washington, DC: PAHO; 2020."},{"key":"ref8","unstructured":"Collin J, Ralston R, Hill SE, Westerman L. Signalling virtue, promoting harm: unhealthy commodity industries and COVID-19. NCD Alliance, SPECTRUM; 2020."},{"key":"ref9","unstructured":"World Health Organization (WHO). The economics of the social determinants of health and health inequalities: a resource book [Internet]. Geneva: WHO; 2013 [cited 2025 Jul 10]. Available from: https:\/\/iris.who.int\/handle\/10665\/84213"},{"key":"ref10","unstructured":"World Health Organization (WHO). WHO technical manual on tobacco tax policy and administration. Geneva: WHO; 2021."},{"key":"ref11","unstructured":"World Health Organization (WHO). WHO manual on sugar-sweetened beverage taxation policies to promote healthy diets. Geneva: WHO; 2022."},{"key":"ref12","unstructured":"World Health Organization (WHO). WHO technical manual on alcohol tax policy and administration. Geneva: WHO; 2023."},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Paraje G, Gomes FS. Expenditures on sugar-sweetened beverages in Jamaica and its association with household budget allocation. BMC Public Health. 2022 Mar 24;22(1):580.","DOI":"10.1186\/s12889-022-12959-7"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Gilmore AB, Fabbri A, Baum F, Bertscher A, Bondy K, Chang HJ, et al. Defining and conceptualising the commercial determinants of health. Lancet. 2023 Apr;401(10383):1194\u2013213.","DOI":"10.1016\/S0140-6736(23)00013-2"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Lacy-Nichols J, Nandi S, Mialon M, McCambridge J, Lee K, Jones A, et al. Conceptualising commercial entities in public health: beyond unhealthy commodities and transnational corporations. Lancet. 2023 Apr;401(10383):1214\u201328.","DOI":"10.1016\/S0140-6736(23)00012-0"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Dorfman L, Cheyne A, Friedman LC, Wadud A, Gottlieb M. Soda and tobacco industry corporate social responsibility campaigns: how do they compare? PLOS Med. 2012 Jun 19;9(6):e1001241.","DOI":"10.1371\/journal.pmed.1001241"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Ulucanlar S, Lauber K, Fabbri A, Hawkins B, Mialon M, Hancock L, et al. corporate political activity: taxonomies and model of corporate influence on public policy. Int J Health Policy Manag. 2023 Dec 1;12(1):1\u201322.","DOI":"10.34172\/ijhpm.2023.7292"},{"key":"ref18","unstructured":"O\u2019Neill Institute for National and Global Health Law. Tobacco industry strategy in Latin American courts: a litigation guide. Washington, DC: O\u2019Neill Institute for National and Global Health Law; 2012."},{"key":"ref19","unstructured":"Valdivieso D, Salgado L, Dorado D, Arcila J. III \u00cdndice Regional de Interferencia de la Industria Tabacalera para los pa\u00edses de Am\u00e9rica Latina y el Caribe: Implementaci\u00f3n del Art\u00edculo 5.3 del Convenio Marco de la OMS para el Control del Tabaco. Washington, DC: Pan American Health Organization; 2023."},{"key":"ref20","unstructured":"Assunta M. Global tobacco industry interference index 2023. Bangkok: Global Center for Good Governance in Tobacco Control; 2023."},{"key":"ref21","unstructured":"World Health Organization (WHO). Global status report on alcohol and health and treatment of substance use disorders. Geneva: WHO; 2024."},{"key":"ref22","unstructured":"World Health Organization (WHO). WHO global report on trends in prevalence of tobacco use 2000\u20132030 [Internet]; 2024 [cited 2025 Jul 11]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240088283"},{"key":"ref23","unstructured":"Monteiro CA, Cannon G, Lawrence M, Costa Louzada ML, Pereira Machado P. Ultra-processed foods, diet quality, and health using the NOVA classification system. Rome: Food and Agriculture Organization; 2019."},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Monteiro CA, Moubarac JC, Cannon G, Ng SW, Popkin B. Ultra- processed products are becoming dominant in the global food system. Obes Rev. 2013;14 Suppl 2:21\u20138. https:\/\/doi.org\/10.1111\/obr.12107","DOI":"10.1111\/obr.12107"},{"key":"ref25","unstructured":"Pan American Health Organization (PAHO). Ultra-processed food and drink products in Latin America: sales, sources, nutrient profiles, and policy implications. Washington, DC: PAHO; 2019."},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Paraje G, Flores Mu\u00f1oz M, Wu DC, Jha P. Reductions in smoking due to ratification of the Framework Convention for Tobacco Control in 171 countries. Nat Med. 2024 Mar;30(3):683\u20139.","DOI":"10.1038\/s41591-024-02806-0"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Gravely S, Giovino GA, Craig L, Commar A, D\u2019Espaignet ET, Schotte K, et al. Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries: an association study. Lancet Public Health. 2017 Apr 1;2(4):e166\u201374.","DOI":"10.1016\/S2468-2667(17)30045-2"},{"key":"ref28","unstructured":"Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2021 (GBD 2021). Seattle: IHME; 2024."},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Pichon-Riviere A, Bardach A, Rodr\u00edguez Cairoli F, Casarini A, Espinola N, Perelli L, et al. Health, economic and social burden of tobacco in Latin America and the expected gains of fully implementing taxes, plain packaging, advertising bans and smoke-free environments control measures: a modelling study. Tob Control. 2023 May 4;33(5):611\u201321. https:\/\/doi.org\/10.1136\/tc-2022-057618","DOI":"10.1136\/tc-2022-057618"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Goodchild M, Nargis N, Tursan d\u2019Espaignet E. Global economic cost of smoking-attributable diseases. Tob Control. 2018 Jan;27(1): 58\u201364.","DOI":"10.1136\/tobaccocontrol-2016-053305"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Hutchinson B, Brispat F, Calder\u00f3n Pinz\u00f3n LV, Sarmiento A, Sol\u00eds E, Nugent R, et al. The case for investment in tobacco control: lessons from four countries in the Americas. Rev Panam Salud P\u00fablica. 2022 Oct 6;46:e174.","DOI":"10.26633\/RPSP.2022.174"},{"key":"ref32","unstructured":"World Health Organization (WHO). The SAFER technical package: five areas of intervention at national and subnational levels. Geneva: WHO; 2019."},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Ding C, O'Neill D, Bell S, Stamatakis E, Britton A. Association of alcohol consumption with morbidity and mortality in patients with cardiovascular disease: original data and meta-analysis of 48,423 men and women. BMC Med. 2021;19(1):167. https:\/\/doi.org\/10.1186\/s12916-021-02040-2","DOI":"10.1186\/s12916-021-02040-2"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Neuenschwander M, Ballon A, Weber KS, Norat T, Aune D, Schwingshackl L, et al. Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies. BMJ. 2019;366:l2368. https:\/\/doi.org\/10.1136\/bmj.l2368","DOI":"10.1136\/bmj.l2368"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Wood AM, Kaptoge S, Butterworth AS, Willeit P, Warnakula S, Bolton T, et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599_912 current drinkers in 83 prospective studies. Lancet. 2018;391(10129):1513\u201323. https:\/\/doi.org\/10.1016\/S0140-6736(18)30134-X","DOI":"10.1016\/S0140-6736(18)30134-X"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Sherk A, Stockwell T, Chikritzhs T, Andr\u00e9asson S, Angus C, Gripenberg J, et al. Alcohol consumption and the physical availability of take-away alcohol: systematic reviews and meta-analyses of the days and hours of sale and outlet density. J Stud Alcohol Drugs. 2018;79(1):58\u201367.","DOI":"10.15288\/jsad.2018.79.58"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Wicki M, Bertholet N, Gmel G. Estimated changes in hospital admissions for alcohol intoxication after partial bans on off-premises sales of alcoholic beverages in the canton of Vaud, Switzerland: an interrupted time-series analysis. Addiction. 2020;115(8):1459\u201369. https:\/\/doi.org\/10.1111\/add.14967","DOI":"10.1111\/add.14967"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Rehm J, Kilian C, Ferreira-Borges C, Jernigan D, Monteiro M, Parry CDH, et al. Alcohol use in times of the COVID 19: implications for monitoring and policy. Drug Alcohol Rev. 2020;39(4):301\u20134. https:\/\/doi.org\/10.1111\/dar.13074","DOI":"10.1111\/dar.13074"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Carpenter C, Dobkin C. The minimum legal drinking age and crime. Rev Econ Stat. 2015;97(2):521\u20134. https:\/\/doi.org\/10.1162\/REST_a_00489","DOI":"10.1162\/REST_a_00489"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Rossow I, M\u00e4kel\u00e4 P. Public health thinking around alcohol-related harm: why does per capita consumption matter? J Stud Alcohol Drugs. 2021;82(1):9\u201317.","DOI":"10.15288\/jsad.2021.82.9"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Saffer H, Dave D. Alcohol advertising and alcohol consumption by adolescents. Health Econ. 2006;15(6):617\u201337. https:\/\/doi.org\/10.1002\/hec.1091","DOI":"10.1002\/hec.1091"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Jiang H, Livingston M, Room R. Alcohol consumption and fatal injuries in Australia before and after major traffic safety initiatives: a time series analysis. Alcohol Clin Exp Res. 2015;39(1):175\u201383. https:\/\/doi.org\/10.1111\/acer.12609","DOI":"10.1111\/acer.12609"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Kaner EF, Beyer FR, Muirhead C, Campbell F, Pienaar ED, Bertholet N, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2018;2(2):CD004148. https:\/\/doi.org\/10.1002\/14651858.CD004148.pub4","DOI":"10.1002\/14651858.CD004148.pub4"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Rehm J, Shield KD, Gmel G, Rehm MX, Frick U. Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. Eur Neuropsychopharmacol. 2013;23(2):89\u201397. https:\/\/doi.org\/10.1016\/j.euroneuro.2012.08.001","DOI":"10.1016\/j.euroneuro.2012.08.001"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Medina-Mora ME, Monteiro M, Rafful C, Samano I. Comprehensive analysis of alcohol policies in the Latin America and the Caribbean. Drug Alcohol Rev. 2021;40(3):385\u2013401. https:\/\/doi.org\/10.1111\/dar.13227","DOI":"10.1111\/dar.13227"},{"key":"ref46","unstructured":"World Health Organization (WHO). Global health observatory data. Geneva: WHO; 2025."},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Soares APDC, Pereira CG, Santana ML, Gomes FDS, Anast\u00e1cio LR. Efficacy of Brazilian and Mexican front-of-package nutrition labeling systems on simulated online purchase of non-alcoholic beverages by adolescents: a randomized controlled study. Food Res Int. 2025 Feb;202:115539. https:\/\/doi.org\/10.1016\/j.foodres.2024.115539","DOI":"10.1016\/j.foodres.2024.115539"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Gomes FS, Madriz-Morales K, Valenzuela DR, Blanco-Metzler A, Amador N, Benavides-Aguilar K, et al. Comparison of front-of-package nutrition labelling schemes in Costa Rica: a multi-arm parallel-group randomised controlled trial assessing objective understanding and purchase intention. Appetite. 2025;206:107774. https:\/\/doi.org\/10.1016\/j.appet.2024.107774","DOI":"10.1016\/j.appet.2024.107774"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Gomes FS, R\u00edos-Castillo I, Correa LRL, Cruzado B, Rojas CFU, Ares Devincenzi G, et al. Effects of front-of-package nutrition labelling systems on objective understanding and purchase intention in Panama: results from a multi-arm parallel-group randomised controlled trial. Public Health Nutr. 2024;27(1):e192. https:\/\/doi.org\/10.1017\/S1368980024001009","DOI":"10.1017\/S1368980024001009"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"White-Barrow V, Gomes FS, Eyre S, Ares G, Morris A, Caines D, et al. Effects of front-of-package nutrition labelling systems on understanding and purchase intention in Jamaica: results from a multiarm randomised controlled trial. BMJ Open. 2023;13(4):e065620. https:\/\/doi.org\/10.1136\/bmjopen-2022-065620","DOI":"10.1136\/bmjopen-2022-065620"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Ares G, Ant\u00fanez L, Curutchet MR, Galicia L, Moratorio X, Gim\u00e9nez A, et al. Immediate effects of the implementation of nutritional warnings in Uruguay: awareness, self-reported use and increased understanding. Public Health Nutr. 2021;24(2):364\u201375. https:\/\/doi.org\/10.1017\/S1368980020002517","DOI":"10.1017\/S1368980020002517"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Basto-Abreu A, Torres-Alvarez R, Reyes-S\u00e1nchez F, Gonz\u00e1lez- Morales R, Canto-Osorio F, Colchero MA, et al. Predicting obesity reduction after implementing warning labels in Mexico: a modeling study. PLoS Med. 2020;17(7):e1003221. https:\/\/doi.org\/10.1371\/journal.pmed.1003221","DOI":"10.1371\/journal.pmed.1003221"},{"key":"ref53","unstructured":"Pan American Health Organization (PAHO). Front-of-package warning labels save lives and resources: results from a modeling study in Barbados. Washington, DC: PAHO; 2023."},{"key":"ref54","unstructured":"Pan American Health Organization (PAHO). Pan American Health Organization nutrient profile model. Washington, DC: PAHO; 2016."},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Canella DS, Pereira Montera VDS, Oliveira N, Mais LA, Andrade GC, Martins APB. Food additives and PAHO's nutrient profile model as contributors' elements to the identification of ultra- processed food products. Sci Rep. 2023;13(1):13698. https:\/\/doi.org\/10.1038\/s41598-023-40650-3","DOI":"10.1038\/s41598-023-40650-3"},{"key":"ref56","unstructured":"Pan American Health Organization (PAHO). Consumption of ultra-processed and processed foods with excessive nutrients associated with noncommunicable chronic diseases and unhealthy diets in the Americas. Washington, DC: PAHO; 2023."},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Crosbie E, Gomes FS, Olvera J, Rinc\u00f3n-Gallardo Pati\u00f1o S, Hoeper S, Carriedo A. A policy study on front-of-pack nutrition labeling in the Americas: emerging developments and outcomes. Lancet Reg Health Am. 2022;18:100400. https:\/\/doi.org\/10.1016\/j.lana.2022.100400.","DOI":"10.1016\/j.lana.2022.100400"},{"key":"ref58","unstructured":"Pan American Health Organization (PAHO). Food, nutrition, and physical activity initiatives in schools in the Americas. Washington, DC: PAHO; 2025."},{"key":"ref59","unstructured":"Pan American Health Organization (PAHO). Regulation of food advertising in the Americas. Case studies from Brazil, Chile, Mexico, and Peru. Washington, DC: PAHO; 2025."},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Steele L, Drummond E, Nishida C, Yamamoto R, Branca F, Parsons Perez C, et al. Ending trans fat\u2014the first-ever global elimination program for a noncommunicable disease risk factor: JACC International. J Am Coll Cardiol. 2024;84(7):663\u201374. https:\/\/doi.org\/10.1016\/j.jacc.2024.04.067","DOI":"10.1016\/j.jacc.2024.04.067"},{"key":"ref61","unstructured":"World Health Organization (WHO). Replace trans fat. An action package to eliminate industrially-produced trans-fatty acids. Geneva: WHO; 2018."},{"key":"ref62","unstructured":"Pan American Health Organization (PAHO). Plan of action for the elimination of industrially produced trans-fatty acids 2020\u20132025. Washington, DC: PAHO; 2020."},{"key":"ref63","unstructured":"Pan American Health Organization (PAHO). ENLACE: data portal on noncommunicable diseases, mental health, and external causes. Washington, DC: PAHO; 2025."},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Ch\u00e1vez CG, Barrientos-Gutierrez T, Ng SW, Rivera JA, Colchero MA. Changes in sugar-sweetened beverages and non-essential energy-dense food purchases overall and by type before and after the implementation of taxes in Mexico: repeated cross-sectional national surveys (2008\u20132018). BMJ Public Health. 2025;3(1):e001524. https:\/\/doi.org\/10.1136\/bmjph-2024-001524","DOI":"10.1136\/bmjph-2024-001524"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Salgado Hernandez JC, Ng SW, Stearns SC, Trogdon JG. Cost-benefit analysis of alternative tax policies on sugar-sweetened beverages in Mexico. PLoS One. 2023;18(10):e0292276. https:\/\/doi.org\/10.1371\/journal.pone.0292276","DOI":"10.1371\/journal.pone.0292276"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Roche M, Alvarado M, Sandoval RC, Gomes FDS, Paraje G. Comparing taxes as a percentage of sugar-sweetened beverage prices in Latin America and the Caribbean. Lancet Reg Health Am. 2022;11:100257. https:\/\/doi.org\/10.1016\/j.lana.2022.100257","DOI":"10.1016\/j.lana.2022.100257"},{"key":"ref67","unstructured":"Pan American Health Organization (PAHO). PAHO\u2019s strategy and plan of action to strengthen tobacco control in the region of the Americas 2025\u20132030. Washington, DC: PAHO; 2024."},{"key":"ref68","unstructured":"World Health Organization (WHO). Global strategy to reduce the harmful use of alcohol. Geneva: WHO; 2010."}],"container-title":["Revista Panamericana de Salud P\u00fablica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iris.paho.org\/bitstreams\/027789d4-4265-4942-87dc-b10d8c49d0a3\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:59:08Z","timestamp":1772798348000},"score":1,"resource":{"primary":{"URL":"https:\/\/iris.paho.org\/handle\/10665.2\/70776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":68,"alternative-id":["RPSP.2026.11"],"URL":"https:\/\/doi.org\/10.26633\/rpsp.2026.11","relation":{},"ISSN":["1020-4989","1680-5348"],"issn-type":[{"value":"1020-4989","type":"print"},{"value":"1680-5348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]}}}